193 related articles for article (PubMed ID: 12964047)
21. Betagamma subunits of G(i/o) suppress EGF-induced ERK5 phosphorylation, whereas ERK1/2 phosphorylation is enhanced.
Obara Y; Okano Y; Ono S; Yamauchi A; Hoshino T; Kurose H; Nakahata N
Cell Signal; 2008 Jul; 20(7):1275-83. PubMed ID: 18407464
[TBL] [Abstract][Full Text] [Related]
22. Leukemia inhibitory factor-transfected embryonic fibroblasts and vascular endothelial growth factor successfully improve the skin substitute wound healing by increasing angiogenesis and matrix production.
Akita S; Daian T; Ishihara H; Fujii T; Akino K
J Dermatol Sci; 2004 Oct; 36(1):11-23. PubMed ID: 15488701
[TBL] [Abstract][Full Text] [Related]
23. Regulation of vascular endothelial growth factor expression by EMMPRIN via the PI3K-Akt signaling pathway.
Tang Y; Nakada MT; Rafferty P; Laraio J; McCabe FL; Millar H; Cunningham M; Snyder LA; Bugelski P; Yan L
Mol Cancer Res; 2006 Jun; 4(6):371-7. PubMed ID: 16778084
[TBL] [Abstract][Full Text] [Related]
24. Lysophosphatidic acid-induced ERK activation and chemotaxis in MC3T3-E1 preosteoblasts are independent of EGF receptor transactivation.
Karagiosis SA; Chrisler WB; Bollinger N; Karin NJ
J Cell Physiol; 2009 Jun; 219(3):716-23. PubMed ID: 19189345
[TBL] [Abstract][Full Text] [Related]
25. The protein-tyrosine phosphatase DEP-1 modulates growth factor-stimulated cell migration and cell-matrix adhesion.
Jandt E; Denner K; Kovalenko M; Ostman A; Böhmer FD
Oncogene; 2003 Jul; 22(27):4175-85. PubMed ID: 12833140
[TBL] [Abstract][Full Text] [Related]
26. Betacellulin and amphiregulin induce upregulation of cyclin D1 and DNA synthesis activity through differential signaling pathways in vascular smooth muscle cells.
Shin HS; Lee HJ; Nishida M; Lee MS; Tamura R; Yamashita S; Matsuzawa Y; Lee IK; Koh GY
Circ Res; 2003 Aug; 93(4):302-10. PubMed ID: 12869389
[TBL] [Abstract][Full Text] [Related]
27. HIF1α-Induced by Lysophosphatidic Acid Is Stabilized via Interaction with MIF and CSN5.
No YR; Lee SJ; Kumar A; Yun CC
PLoS One; 2015; 10(9):e0137513. PubMed ID: 26352431
[TBL] [Abstract][Full Text] [Related]
28. Up-regulation of vascular endothelial growth factor in breast cancer cells by the heregulin-beta1-activated p38 signaling pathway enhances endothelial cell migration.
Xiong S; Grijalva R; Zhang L; Nguyen NT; Pisters PW; Pollock RE; Yu D
Cancer Res; 2001 Feb; 61(4):1727-32. PubMed ID: 11245489
[TBL] [Abstract][Full Text] [Related]
29. Blocking angiogenesis and tumorigenesis with GFA-116, a synthetic molecule that inhibits binding of vascular endothelial growth factor to its receptor.
Sun J; Blaskovich MA; Jain RK; Delarue F; Paris D; Brem S; Wotoczek-Obadia M; Lin Q; Coppola D; Choi K; Mullan M; Hamilton AD; Sebti SM
Cancer Res; 2004 May; 64(10):3586-92. PubMed ID: 15150116
[TBL] [Abstract][Full Text] [Related]
30. Small interfering RNA-mediated down-regulation of caveolin-1 differentially modulates signaling pathways in endothelial cells.
Gonzalez E; Nagiel A; Lin AJ; Golan DE; Michel T
J Biol Chem; 2004 Sep; 279(39):40659-69. PubMed ID: 15292187
[TBL] [Abstract][Full Text] [Related]
31. Ligand- and cell-specific effects of signal transduction pathway inhibitors on progestin-induced vascular endothelial growth factor levels in human breast cancer cells.
Wu J; Brandt S; Hyder SM
Mol Endocrinol; 2005 Feb; 19(2):312-26. PubMed ID: 15528272
[TBL] [Abstract][Full Text] [Related]
32. P115 promotes growth of gastric cancer through interaction with macrophage migration inhibitory factor.
Li XJ; Luo Y; Yi YF
World J Gastroenterol; 2013 Dec; 19(46):8619-29. PubMed ID: 24379579
[TBL] [Abstract][Full Text] [Related]
33. Macrophage migratory inhibitory factor promotes bladder cancer progression via increasing proliferation and angiogenesis.
Choudhary S; Hegde P; Pruitt JR; Sielecki TM; Choudhary D; Scarpato K; Degraff DJ; Pilbeam CC; Taylor JA
Carcinogenesis; 2013 Dec; 34(12):2891-9. PubMed ID: 23825153
[TBL] [Abstract][Full Text] [Related]
34. Hypoxia enhances LPA-induced HIF-1alpha and VEGF expression: their inhibition by resveratrol.
Park SY; Jeong KJ; Lee J; Yoon DS; Choi WS; Kim YK; Han JW; Kim YM; Kim BK; Lee HY
Cancer Lett; 2007 Dec; 258(1):63-9. PubMed ID: 17919812
[TBL] [Abstract][Full Text] [Related]
35. Ras/MEK pathway is required for NGF-induced expression of tyrosine hydroxylase gene.
Suzuki T; Kurahashi H; Ichinose H
Biochem Biophys Res Commun; 2004 Mar; 315(2):389-96. PubMed ID: 14766220
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of tumor growth and metastasis in vitro and in vivo by targeting macrophage migration inhibitory factor in human neuroblastoma.
Ren Y; Chan HM; Fan J; Xie Y; Chen YX; Li W; Jiang GP; Liu Q; Meinhardt A; Tam PK
Oncogene; 2006 Jun; 25(25):3501-8. PubMed ID: 16449971
[TBL] [Abstract][Full Text] [Related]
37. High expression of macrophage migration inhibitory factor in human melanoma cells and its role in tumor cell growth and angiogenesis.
Shimizu T; Abe R; Nakamura H; Ohkawara A; Suzuki M; Nishihira J
Biochem Biophys Res Commun; 1999 Nov; 264(3):751-8. PubMed ID: 10544003
[TBL] [Abstract][Full Text] [Related]
38. Disruption of fibroblast growth factor signal pathway inhibits the growth of synovial sarcomas: potential application of signal inhibitors to molecular target therapy.
Ishibe T; Nakayama T; Okamoto T; Aoyama T; Nishijo K; Shibata KR; Shima Y; Nagayama S; Katagiri T; Nakamura Y; Nakamura T; Toguchida J
Clin Cancer Res; 2005 Apr; 11(7):2702-12. PubMed ID: 15814652
[TBL] [Abstract][Full Text] [Related]
39. SU5416 inhibited VEGF and HIF-1alpha expression through the PI3K/AKT/p70S6K1 signaling pathway.
Zhong XS; Zheng JZ; Reed E; Jiang BH
Biochem Biophys Res Commun; 2004 Nov; 324(2):471-80. PubMed ID: 15474452
[TBL] [Abstract][Full Text] [Related]
40. Blockade of insulin-like growth factor I receptor function inhibits growth and angiogenesis of colon cancer.
Reinmuth N; Liu W; Fan F; Jung YD; Ahmad SA; Stoeltzing O; Bucana CD; Radinsky R; Ellis LM
Clin Cancer Res; 2002 Oct; 8(10):3259-69. PubMed ID: 12374697
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
